智通财经APP获悉，百心安-B(02185)午后涨近12%，截至发稿，涨11.93%，报6.85港元，成交额430.19万港元。
消息面上，11月26日，百心安-B发布公告，最近，公司附属公司上海安通医疗科技有限公司(安通)研发的Iberis®多极肾动脉射频消融导管系统(Iberis® RDN系统)已在新西兰完成新西兰药品和医疗器械安全管理局(Medsafe)的注册。
截至本公告日期，Iberis® RDN系统是全球唯一获准使用经桡动脉方法(TRA)和经股动脉入路方法(TFA)的肾神经阻断(RDN)产品。TRA使RDN更安全、更有效、更便宜。公司的最终目标是为全球患者提供门诊RDN手术。安通已于2016年于欧洲取得Iberis® RDN系统的CE标志。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.